BOSTON, May 8, 2025 /PRNewswire/ — Ratio Therapeutics Inc. (Ratio), a pharmaceutical company employing innovative technologies to develop best-in-class radiopharmaceuticals for cancer treatment and monitoring, today announced that it entered into an agreement with the Medical Innovation Technology Management division of Wasatch Group to […] The post May 8th, 2025: Ratio Therapeutics to Establish New Radiopharmaceutical Manufacturing Facility first appeared on Ratio Therapeutics .